DudeMeds vs SkinnyRx
SkinnyRx has an open FDA warning letter dated February 20, 2026. DudeMeds has none. On brand-name semaglutide pen, SkinnyRx costs $2,220 less a year at standing rates: $1,400 a month against $1,585 a month at DudeMeds. It is one of two products the two sell at comparable terms.
To see where both sit among the other sellers, read our best weight-loss injection providers board.
The record
DudeMeds / SkinnyRx
DudeMeds
6.8/10
SkinnyRx
6.3/10
Both DudeMeds and SkinnyRx are affiliate partners: we are paid if you sign up through our links. Neither is featured. Scores are computed the same way for both (DudeMeds 6.8, SkinnyRx 6.3). How we are paid
What the record shows
- 01
SkinnyRx has an open FDA warning letter dated February 20, 2026. DudeMeds has none.
- 02
Neither names the pharmacy that compounds its medication.
- 03
On brand-name semaglutide pen, SkinnyRx costs $2,220 less a year at standing rates: $1,400 a month against $1,585 a month at DudeMeds. It is one of two products the two sell at comparable terms.
- 04
Only SkinnyRx lists a price for compounded oral semaglutide, compounded oral tirzepatide and brand-name semaglutide pill.
- 05
DudeMeds covers two states SkinnyRx does not and SkinnyRx covers four states DudeMeds does not.
- 06
DudeMeds holds you to a prepaid 2- to 4-month kits that auto-renew; SkinnyRx states you can cancel at any time.
Prices and terms, product by product
A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.
DudeMeds
SkinnyRx
$179/mo
$2,148 a year
$99/mo
first month only; not compared
$233/mo
$2,796 a year
$99/mo
first month only; not compared
$1,585/mo
$19,020 a year
$1,400/moLower
$16,800 a year
$1,350/moLower
$16,200 a year
$1,400/mo
$16,800 a year
$149/mo
first month only; not compared
$199/mo
first month only; not compared
$248/mo
$2,976 a year
$248/mo
$2,976 a year
Read off each seller’s own pages. DudeMeds: October 17, 2026. SkinnyRx: October 30, 2026. Every plan and dose we hold is on the full review.
The case for each
The case for DudeMeds
6.8/10- No FDA warning letter on record
- $600 a year less on brand-name tirzepatide pen
- Names no compounding pharmacy
- Minimum commitment before you can cancel
The case for SkinnyRx
6.3/10- $2,220 a year less on brand-name semaglutide pen
- Sells compounded oral semaglutide and compounded oral tirzepatide, which DudeMeds does not price
- States you can cancel at any time
- Open FDA warning letter, February 20, 2026
- Names no compounding pharmacy
Scores
DudeMeds 6.8 · SkinnyRx 6.3 out of 10. Six weighted parts.
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
The score is the same formula for every seller. Payment does not enter it. Method
DudeMeds vs SkinnyRx: questions
Other sellers we are paid by
Affiliate partners outside this pair. Each has its own record and review, scored the same way.
- Embody9.3
From $79/mo
Visit site - Collective9.1
From $59/mo
Visit site - AgelessRx7.4
From $99/mo prepaid
Visit site
Sellers closest to these two
- DudeMeds vs Gala
- DudeMeds vs Direct Meds
- DudeMeds vs Embody
- DudeMeds vs CoreAge Rx
- SkinnyRx vs Found
- SkinnyRx vs ShedRx
Matched on molecule, form and price. Every pair we list · The register
Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks